2016

Dysregulated bioenergetics: a key regulator of joint inflammation.

Biniecka M, Canavan M, McGarry T, Gao W, McCormick J, Cregan S, Gallagher L, Smith T, Phelan JJ, Ryan J, O’Sullivan J, Ng CT, Veale DJ, Fearon U. Ann Rheum Dis. 2016 Dec;75(12):2192-2200

Ustekinumab for the treatment of refractory giant cell arteritis.

Conway R, O’Neill L, O’Flynn E, Gallagher P, McCarthy GM, Murphy CC, Veale DJ, Fearon U, Molloy ES.

Ann Rheum Dis. 2016 Aug;75(8):1578-9.

Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms.

Connolly M, Rooney PR, McGarry T, Maratha AX, McCormick J, Miggin SM, Veale DJ, Fearon U.

Ann Rheum Dis. 2016 Jul;75(7):1392-8

Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.

Fearon U, Canavan M, Biniecka M, Veale DJ.

Nat Rev Rheumatol. 2016 Jul;12(7):385-97

Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.

Gao W, McGarry T, Orr C, McCormick J, Veale DJ, Fearon U.

Ann Rheum Dis. 2016 Jan;75(1):311-5